CompaniesPezeshk Khoob

Pezeshk Khoob

HealthtechConsumer health platformIn the registry
Entity IDIR-CO-2393
SectorHealthtech
FoundedCoverage pending
HQCoverage pending
VerificationReported
Last reviewed2026-09-03

Consumer health platform, brand پزشک خوب, operated by Payeshgaran Novin Salamat va Darman. Revenue of 20.2 billion toman in the year to March 2025, up 136 percent, and profitable, per the audited filing of a former venture shareholder, which sold its 10.87 percent stake to the founder and other shareholders in September 2025 at 9.1 times cost.

Tehran Index tracks this company as part of a source-linked research record on Iran’s technology economy. Access opens to a limited first cohort. Register for access, or browse the registry.

Operating metrics, period-stamped
RevenueYears ended 20 March 2025 and 19 March 2024Official record
20.2 billion toman (201,884 million rial), after 8.6 billion toman (85,526 million rial) the year before
Arman Ati venture fund, audited financial statements for the year to 20 March 2026, note 11-9, Codal tracing number 1557615 · retrieved 2026-09-02Up 136 percent. Per note 11-9-1 the March 2025 figures come from the company's tax return, not audited accounts. Disclosed by a shareholder; the company publishes no accounts. No dollar equivalent: no sourced rate exists for these periods.
Net profitYears ended 20 March 2025 and 19 March 2024Official record
1.8 billion toman (18,150 million rial), after 1.8 billion toman (17,756 million rial) the year before
Arman Ati venture fund, audited financial statements for the year to 20 March 2026, note 11-9, Codal tracing number 1557615 · retrieved 2026-09-02A net margin of about 9 percent in the later year on revenue that more than doubled. Tax-return basis for the later year.
Balance sheet20 March 2025Official record
Assets 6.5 billion toman, liabilities 3.7 billion toman, equity 2.9 billion toman (65,220, 36,577 and 28,643 million rial)
Arman Ati venture fund, audited financial statements for the year to 20 March 2026, note 11-9, Codal tracing number 1557615 · retrieved 2026-09-02Reconciles exactly. The March 2024 comparative is printed with an extra digit in the assets line (250,010 against liabilities plus equity of 25,010) and is not loaded.
Ownership & capital
Venture shareholder exitContract dated 13 September 2025Official record
Arman Ati venture fund sold its 10.87 percent, 108,700,000 shares, to the founder and other shareholders for 27,250,000,000 rial (2.725 billion toman), against a cost of 3,000,000,000 rial
Arman Ati venture fund, audited financial statements for the year to 20 March 2026, notes 11 and 11-8, Codal tracing number 1557615 · retrieved 2026-09-02A 9.1 times cash multiple for the fund; the entry date is not stated in the filing, only the prior-year carrying cost. A secondary sale to insiders, which is the common exit route for Iranian venture funds. The price is disclosed; any whole-company valuation derived from it is not published.
Source ledger, every field, its evidence
Venture shareholder exitOfficial recordContract dated 13 September 2025
Arman Ati venture fund sold its 10.87 percent, 108,700,000 shares, to the founder and other shareholders for 27,250,000,000 rial (2.725 billion toman), against a cost of 3,000,000,000 rial
RevenueOfficial recordYears ended 20 March 2025 and 19 March 2024
20.2 billion toman (201,884 million rial), after 8.6 billion toman (85,526 million rial) the year before
Net profitOfficial recordYears ended 20 March 2025 and 19 March 2024
1.8 billion toman (18,150 million rial), after 1.8 billion toman (17,756 million rial) the year before
Balance sheetOfficial record20 March 2025
Assets 6.5 billion toman, liabilities 3.7 billion toman, equity 2.9 billion toman (65,220, 36,577 and 28,643 million rial)

Last full review: 2026-09-03 · Tehran Index research desk · corrections: desk@tehranindex.com

Work with this record

Alerts, company comparisons, and full-history exports are joining the partner workspace. Request access →

Registered entity
Entity notesIdentity anchored to the legal name printed in the Arman Ati venture fund's audited statements (Codal tracing 1557615), which gives the brand in parentheses. NOT PezeshkBook (pezeshkbook, legal name پردازش موازی آریا), a different company. Product detail, website and registry numbers not yet sourced.
Evidence & verification
Verification tierReported, single public source
Primary evidencewww.codal.ir
Registry identifiersWithheld for compliance

Fields on this profile derive from linked public sources or the official company registry; unknown values stay blank rather than guessed, and estimates are always labelled. How we verify →

Quick facts
Institutional access

This dossier shows the working standard. Institutional access will add a scoped custom dossier or watchlist, the weekly briefing, sourced research requests, coverage reviews, and dataset exports. It is not open yet; the first cohort is being registered now.

Request Access